ZA200708701B - Methods and nucleic acids for analyses of cellular proliferative disorders - Google Patents
Methods and nucleic acids for analyses of cellular proliferative disordersInfo
- Publication number
- ZA200708701B ZA200708701B ZA200708701A ZA200708701A ZA200708701B ZA 200708701 B ZA200708701 B ZA 200708701B ZA 200708701 A ZA200708701 A ZA 200708701A ZA 200708701 A ZA200708701 A ZA 200708701A ZA 200708701 B ZA200708701 B ZA 200708701B
- Authority
- ZA
- South Africa
- Prior art keywords
- analyses
- methods
- nucleic acids
- proliferative disorders
- cellular proliferative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67224205P | 2005-04-15 | 2005-04-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200708701B true ZA200708701B (en) | 2008-11-26 |
Family
ID=39307956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200708701A ZA200708701B (en) | 2005-04-15 | 2007-10-11 | Methods and nucleic acids for analyses of cellular proliferative disorders |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101160411B (zh) |
ZA (1) | ZA200708701B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2279478A1 (en) * | 2008-05-12 | 2011-02-02 | Koninklijke Philips Electronics N.V. | A medical analysis system |
KR102461235B1 (ko) * | 2014-06-04 | 2022-10-28 | 퀘스트 다이어그노스틱스 인베스트먼츠 인코포레이티드 | 결장직장암에 대한 메틸화된 마커 |
CN104745575B (zh) | 2014-08-08 | 2019-03-12 | 博诚研究中心 | 用于检测细胞增殖性异常或疾病程度分级的基因组合物及其用途 |
CN104745681B (zh) * | 2014-08-08 | 2018-11-06 | 博尔诚(北京)科技有限公司 | 多元基因组合物及其用途 |
CN105755107A (zh) * | 2014-12-18 | 2016-07-13 | 博诚研究中心 | 用于预测和诊断大肠肿瘤和癌前病变的联合检测试剂盒及其用途 |
US20180143198A1 (en) * | 2014-12-26 | 2018-05-24 | Peking University | Method for detecting differentially methylated cpg islands associated with abnormal state of human body |
CN106834426B (zh) * | 2015-12-04 | 2022-07-29 | 博尔诚(北京)科技有限公司 | 用于检测胰腺癌的组合物及其用途 |
CN108159434B (zh) * | 2018-01-29 | 2020-03-24 | 上海市第一人民医院 | 一种基因载体及其用于治疗青光眼的基因治疗药物 |
CN116064815A (zh) * | 2019-02-14 | 2023-05-05 | 博尔诚(北京)科技有限公司 | 一种食管癌、胃癌、肠癌、肝癌和/或胰腺癌患癌、癌前筛查组合物及其用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6783933B1 (en) * | 1999-09-15 | 2004-08-31 | The Johns Hopkins University School Of Medicine | CACNA1G polynucleotide, polypeptide and methods of use therefor |
WO2004074441A2 (en) * | 2003-02-19 | 2004-09-02 | Government Of The United States Of America Represented By The Secretary Department Of Health And Human Services | Amplification or overexpression of mll septin-like fusion (msf) and septin9 and methods related thereto |
-
2006
- 2006-04-17 CN CN200680012490.0A patent/CN101160411B/zh active Active
-
2007
- 2007-10-11 ZA ZA200708701A patent/ZA200708701B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN101160411A (zh) | 2008-04-09 |
CN101160411B (zh) | 2014-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200708701B (en) | Methods and nucleic acids for analyses of cellular proliferative disorders | |
EP1856291A4 (en) | NUCLEIC ACIDS AND PROTEINS, AND METHODS OF MAKING AND USING SAME | |
EP1812031A4 (en) | COMPOSITIONS AND METHOD FOR MODIFYING BIOMOLECULES | |
EP1851332A4 (en) | METHOD AND COMPOSITIONS FOR THE EVALUATION OF NUCLEIC ACIDS | |
IL188206A0 (en) | Materials and methods for transcribing nucleic acids | |
ZA200805741B (en) | Anti-MN antibodies and methods of using same | |
EP1854539A4 (en) | CATALYTIC EFFECTIVE MATERIAL AND ASSOCIATED METHOD OF MANUFACTURE | |
IL189449A0 (en) | Method for enhancing the effect of particulate benefit agents | |
IL181974A0 (en) | Simplified methods for isolating nucleic acids from cellular materials | |
EP1898752A4 (en) | BODY SUPPORT DEVICE CONSISTING OF RETICULATED MATERIAL AND ASSOCIATED METHOD | |
EP1943348A4 (en) | COMPOSITIONS, METHODS AND KITS FOR AMPLIFICATION OF NUCLEIC ACIDS | |
PL1937834T3 (pl) | Sposoby wzmacniania, kwantyfikacji i identyfikacji kwasów nukleinowych | |
PL1874770T3 (pl) | Fenyloacetamidy odpowiednie jako inhibitory kinaz białkowych | |
EP1937849A4 (en) | METHODS AND COMPOSITIONS FOR NUCLEIC ACID MARKING | |
EP1930502A4 (en) | ROAD COATING MATERIAL AND METHOD FOR MANUFACTURING COATED BODY USING SAID MATERIAL | |
IL188036A0 (en) | Methods and apparatus for improving the sensitivity of capillary zone electrophoresis | |
EP1922086A4 (en) | TARGETED PROTEIN KINASE C HEMMER AND ITS USES | |
IL189402A0 (en) | Methods and compositions for dried cellular forms | |
EP1853520A4 (en) | METAL ADSORPTION METHOD AND ADSORPTION MATERIAL USED IN THIS METHOD AND METHOD OF REUSING THE ADSORPTION MATERIAL | |
EP1953541A4 (en) | METHOD FOR DETERMINING DOUBLE-STRANDED DNA QUANTITY AND DETERMINING KIT | |
EP1880024A4 (en) | GHSR POLYMORPHIC NUCLEIC ACIDS AND USES THEREOF | |
IL187832A0 (en) | Methods and intermediates for the preparation of optionally radio- labeled imatinib | |
EP1924714A4 (en) | Quantification of nucleic acids with internal calibration curve | |
PL1919951T3 (pl) | Przeciwciała anty-TNF-alfa oraz ich zastosowania | |
EP1732900A4 (en) | ACRYLONITRILE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF INFLAMMATION AND IMMUNE DISORDERS |